MedWatch

Audientes has first day of trading on Spotlight exchange

On Sept. 19, shares of the hearing firm were open for trading on a new exchange after the company made the switch away from the Nasdaq First North Growth Market.

Photo: Audientes / PR

Audientes, a Denmark-based manufacturer of low-cost hearing aids, had its first day of trading, Sept. 19, on Swedish stock exchange Spotlight, a company press release announces.

The company had been listed on First North since September 2020 until the switch to Spotlight was approved in June.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs